Pretargeting with the affinity enhancement system for radioimmunotherapy.

@article{Barbet1999PretargetingWT,
  title={Pretargeting with the affinity enhancement system for radioimmunotherapy.},
  author={Jacques Barbet and Françoise Kraeber-Bod{\'e}r{\'e} and Jean Philippe Vuillez and Emmanuel Gautherot and Eric Rouvier and J. F. Chatal},
  journal={Cancer biotherapy & radiopharmaceuticals},
  year={1999},
  volume={14 3},
  pages={153-66}
}
The pretargeting technique referred to as the Affinity Enhancement System (AES) uses bispecific antibodies and radiolabeled bivalent haptens that bind cooperatively to target cells in vivo. Experimental and clinical data demonstrate that AES can deliver large radiation doses to tumor cells with high tumor to normal tissue contrast ratios and long activity residence time in tumors. Preliminary clinical results of radioimmunotherapy of medullary thyroid carcinomas and lung cancers look promising. 

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Advancing role of radiolabeled antibodies in the therapy of cancer

Cancer Immunology, Immunotherapy • 2003
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…